Elitra Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2000
Total raised
- $22M
Investors
- 10
About Elitra Pharmaceuticals
Elitra Pharmaceuticals engages in discovering, developing, and commercializing the next generation of antimicrobial drugs that target essential gene products of pathogenic organisms.
Who invested in Elitra Pharmaceuticals
10 investors across 1 round
See all investors in Elitra Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Aug 23, 2000
Amount
$22M
Investors
Questions about Elitra Pharmaceuticals
Who invested in Elitra Pharmaceuticals?
Elitra Pharmaceuticals has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elitra Pharmaceuticals raised?
Elitra Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Elitra Pharmaceuticals last raise money?
Elitra Pharmaceuticals's most recent round on record is a Series C, in Aug 2000.
What does Elitra Pharmaceuticals do?
Elitra Pharmaceuticals engages in discovering, developing, and commercializing the next generation of antimicrobial drugs that target essential gene products of pathogenic organisms.
Where is Elitra Pharmaceuticals headquartered?
Elitra Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Elitra Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elitra Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Elitra Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.